New research presented at the 2025 American Society for Clinical Oncology’s (ASCO) annual meeting has shed light on the ...

Colorectal cancer offered the earliest window into the trend of increased cancer incidence among those younger than age 50.

The world’s largest meeting on cancer research has brought promising updates on treatment and prevention for colorectal ...

Abstracts published ahead of the 2025 American Society of Clinical Oncology Annual Meeting found persistent ovarian cancer survival disparities among racial and ethnic subgroups, particularly ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...

Adding immunotherapy to chemotherapy after surgery for stage 3 colon cancer may help decrease recurrence and death rate by 50 ...

Patients who have completed colon cancer treatment could cut their risk of cancer-related death by 37% if they stick to a ...

Several oral abstracts presented at the American Society of Clinical Oncology’s annual meeting highlight ongoing research of Keytruda, Opdivo, Tecentriq and more in skin cancer.

A phase 2 trial shows promising results for pembrolizumab combined with cisplatin and radiation in treating unresectable ...

New data support the role of structured exercise and low inflammatory diets to improve survival and quality of life following ...

Researchers report that a three-year exercise program helped improve survival rates for people who have been treated for ...